(Q40027466)

16 September 2017

title

Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits (English)

1 reference

16 September 2017

5

Carmen Scheibenbogen

1 reference

16 September 2017

9

Ulrich Keilholz

1 reference

16 September 2017

1

Antonia Busse

1 reference

16 September 2017

7

Igor Wolfgang Blau

1 reference

16 September 2017

Marianne Kraus

2

1 reference

16 September 2017

Il-Kang Na

3

1 reference

16 September 2017

Anika Rietz

4

1 reference

16 September 2017

Christoph Driessen

6

1 reference

16 September 2017

Eckhard Thiel

8

1 reference

16 September 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

16 September 2017

1 reference

16 September 2017

volume

112

1 reference

16 September 2017

issue

3

1 reference

16 September 2017

page(s)

659-670

1 reference

Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation

16 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

Potential for proteasome inhibition in the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Interferon-gamma induces different subunit organizations and functional diversity of proteasomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Proteasome inhibitors: from research tools to drug candidates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Proteasome inhibitors: valuable new tools for cell biologists

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Proteasome inhibition in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

A giant protease with potential to substitute for some functions of the proteasome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

A proteolytic system that compensates for loss of proteasome function

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

TM4: a free, open-source system for microarray data management and analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Beta 2 subunit propeptides influence cooperative proteasome assembly

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Interferon-γ Sensitizes Human Myeloid Leukemia Cells to Death Receptor-mediated Apoptosis by a Pleiotropic Mechanism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23224

7 January 2021

Identifiers

DOI

10.1002/CNCR.23224

1 reference

16 September 2017

1 reference